Glucagon-like peptide-1 receptor agonists and risk of sight-threatening retinopathy in Taiwanese population: A propensity based cohort study
0
Authors
Fu‐Shun Yen
Fu‐Shun Yen•James Wei•Chii‐Min Hwu
Published
August 1, 2024
Abstract
To compare the risk of vision-threatening retinopathy between glucagon-like peptide-1 receptor agonists (GLP-1 RA) use and no use in patients with type 2 diabetes.
